Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 6025 | 1473 | 36.1 | 76% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1070 | 9479 | UVEITIS//CYTOMEGALOVIRUS RETINITIS//OCULAR IMMUNOLOGY AND INFLAMMATION |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CORNEAL TRANSPLANTATION | Author keyword | 31 | 25% | 7% | 110 |
| 2 | ANTERIOR CHAMBER ASSOCIATED IMMUNE DEVIATION ACAID | Author keyword | 27 | 92% | 1% | 11 |
| 3 | ACAID | Author keyword | 27 | 63% | 2% | 27 |
| 4 | IMMUNE PRIVILEGE | Author keyword | 23 | 26% | 5% | 76 |
| 5 | EPENS EYE | Address | 15 | 11% | 9% | 132 |
| 6 | CORNEAL ALLOGRAFT | Author keyword | 15 | 77% | 1% | 10 |
| 7 | CORNEAL GRAFT REJECTION | Author keyword | 14 | 60% | 1% | 15 |
| 8 | CORNEAL ALLOGRAFTS | Author keyword | 11 | 78% | 0% | 7 |
| 9 | ANTERIOR CHAMBER ASSOCIATED IMMUNE DEVIATION | Author keyword | 10 | 50% | 1% | 14 |
| 10 | HIGH RISK KERATOPLASTY | Author keyword | 8 | 52% | 1% | 11 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | IMMUNE DEVIATION ACAID | 81 | 73% | 4% | 62 |
| 2 | DEVIATION ACAID | 72 | 83% | 3% | 40 |
| 3 | ANTERIOR CHAMBER | 65 | 25% | 15% | 226 |
| 4 | ACAID | 52 | 87% | 2% | 26 |
| 5 | HIGH RISK KERATOPLASTY | 48 | 68% | 3% | 42 |
| 6 | PRIVILEGED SITE | 31 | 82% | 1% | 18 |
| 7 | CILIARY BODY CELLS | 27 | 72% | 1% | 21 |
| 8 | HIGH RISK EYES | 26 | 100% | 1% | 11 |
| 9 | CORNEAL ALLOGRAFT SURVIVAL | 24 | 60% | 2% | 26 |
| 10 | ORTHOTOPIC CORNEAL ALLOGRAFTS | 23 | 79% | 1% | 15 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Ocular immune privilege: Therapeutic opportunities from an experiment of nature | 2003 | 265 | 94 | 77% |
| Topical Cyclosporine in Corneal Transplantation | 2015 | 1 | 31 | 65% |
| Corneal graft rejection | 2007 | 73 | 144 | 75% |
| See no evil, hear no evil, do no evil: the lessons of immune privilege | 2006 | 188 | 100 | 38% |
| The immunobiology of corneal transplantation | 2007 | 42 | 88 | 81% |
| Corneal transplantation: The forgotten graft | 2004 | 66 | 52 | 73% |
| Immune mechanisms of corneal allograft rejection | 2007 | 50 | 90 | 66% |
| Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation | 2003 | 111 | 45 | 76% |
| IMMUNE PRIVILEGE AS THE RESULT OF LOCAL TISSUE BARRIERS AND IMMUNOSUPPRESSIVE MICROENVIRONMENTS | 1993 | 135 | 34 | 79% |
| Role of ocular pigment epithelial cells in immune privilege | 2009 | 25 | 37 | 57% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | EPENS EYE | 15 | 11% | 9.0% | 132 |
| 2 | LIONS CROATIAN EYE BANK | 4 | 56% | 0.3% | 5 |
| 3 | CONNECTICUT LIONS VIS | 3 | 100% | 0.2% | 3 |
| 4 | TRAINING PROGRAM MOL BASES EYE DIS | 3 | 100% | 0.2% | 3 |
| 5 | CORNEAL TISSUE REGENERAT | 3 | 24% | 0.7% | 10 |
| 6 | IMMUNOL OPHTHALMOL | 3 | 60% | 0.2% | 3 |
| 7 | SECT CORNEAL TRANSPLANTAT | 3 | 60% | 0.2% | 3 |
| 8 | BIOSTAT CARDIOVASC SURG | 2 | 67% | 0.1% | 2 |
| 9 | OPHTHALMOIMMUNOL | 2 | 16% | 0.7% | 10 |
| 10 | OCULAR IMMUNOL PROGRAM | 2 | 43% | 0.2% | 3 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000154329 | CORNEAL NEOVASCULARIZATION//LIPID KERATOPATHY//HEMANGIOGENESIS |
| 2 | 0.0000126138 | EXPERIMENTAL AUTOIMMUNE UVEORETINITIS//ENDOTOXIN INDUCED UVEITIS//EXPERIMENTAL AUTOIMMUNE UVEITIS |
| 3 | 0.0000103288 | ENDOTHELIAL KERATOPLASTY//PENETRATING KERATOPLASTY//DSAEK |
| 4 | 0.0000082901 | INFLAMMAT REGENERAT MED//NONA D ARGININE//CRCERT |
| 5 | 0.0000073701 | EQUINE RECURRENT UVEITIS//RECURRENT UVEITIS//PERIODIC OPHTHALMIA |
| 6 | 0.0000065839 | MOORENS ULCER//SCLERITIS//INFECTIOUS SCLERITIS |
| 7 | 0.0000051939 | ALLERGIC CONJUNCTIVITIS//VERNAL KERATOCONJUNCTIVITIS//SEASONAL ALLERGIC CONJUNCTIVITIS |
| 8 | 0.0000051244 | ACUTE RETINAL NECROSIS//PROGRESSIVE OUTER RETINAL NECROSIS//ACUTE RETINAL NECROSIS SYNDROME |
| 9 | 0.0000051029 | OCULAR DRUG DELIVERY//OPHTHALMIC DRUG DELIVERY//OCULAR DELIVERY |
| 10 | 0.0000047224 | AMNIOTIC MEMBRANE//LIMBAL STEM CELL DEFICIENCY//LIMBAL STEM CELLS |